Related Experiment Video

Updated: Jul 16, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Methodological Concerns in "Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based

Shoujun Shen1, Jiayan Chen2, Bihua Yao1,2

  • 1Department of Clinical Laboratory, The First People's Hospital of Jiashan, Jiashan Hospital Affiliated to Jiaxing University, Jiaxing, China.

Liver Cancer
|July 15, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Clinical complete responseCombination therapyEvents per variableHepatocellular carcinomaPD-1 inhibitor

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Related Concept Videos